10% Shareholder Achillefs Konstantakopoulos Files Intent to Sell $1.25M in Shares
CMRE sits 85% above its 52-week low of $8.412.
Summary
Achillefs Konstantakopoulos, a 10% shareholder of Costamare Inc., has filed a Form 144 indicating intent to sell approximately $1.25 million worth of common stock, continuing a recent pattern of dispositions.
Key Events · Ownership and Investor Activity · CMRE
-
Intent to Sell Shares
Achillefs Konstantakopoulos, a 10% stockholder, filed a Form 144 to sell 80,159 shares of common stock, valued at approximately $1.25 million.
-
Continuation of Selling Pattern
This filing follows previous Form 144s from the same insider on May 29 and June 1, indicating an ongoing disposition of shares by a significant shareholder.
-
Recent Sales History
In the past three months, the same filer has already sold 428,676 shares, generating gross proceeds of over $6.7 million, highlighting a sustained selling trend.
Analysis · CMRE · Energy & Transportation
This Form 144 indicates a continued intent by a significant 10% shareholder to reduce their stake in Costamare. While the individual amount of $1.25 million is not massive relative to the company's market cap, it is part of a consistent pattern of selling by Achillefs Konstantakopoulos, as evidenced by multiple recent filings. This ongoing disposition by a major investor could create an overhang on the stock, suggesting a lack of conviction or a need for liquidity from a key stakeholder.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CMRE was trading at $15.57 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $8.41 to $18.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.